SRT1720, an agonist of Sirt1, can improve cell viability, promote M2 microglia polarization, suppress inflammatory response and inhibit oxidative damage via modulation of ROS-mediated NLRP3 inflammasome signaling after subarachnoid hemorrhage [40]. The gene discussed is NLRP3; the disease is subarachnoid hemorrhage.